Full-Time

Clinical Respiratory Partner

HME Sales

Posted on 7/11/2025

AdaptHealth

AdaptHealth

1,001-5,000 employees

Home medical equipment provider with rentals

No salary listed

St Paul, MN, USA

In Person

Category
Medical, Clinical & Veterinary (2)
,
Required Skills
Sales
Requirements
  • Associates degree from an AMA approved respiratory program
  • Valid and unrestricted RT clinical license in all states serviced by the branch
  • Or an Associate degree in Nursing, with a valid and unrestricted RN clinical license
  • Must be CPR certified
  • Valid and unrestricted driver’s license in the state of residence
  • Three (3) years of clinical experience as a Health Care RT, HME RT or clinical nursing with Vent experience for Clinical Respiratory Partner
  • Five (5) years of clinical experience as a Health Care RT, HME RT or clinical nursing with Vent experience for Senior Clinical Respiratory Partner
  • Eight (8) years of clinical experience as a Health Care RT, HME RT or clinical nursing with Vent experience for Primary Clinical Respiratory Partner
Responsibilities
  • Identifies, contacts, and builds relationships with referral sources
  • Conducts sales calls in the field to maintain contact with referral sources with information regarding AdaptHealth’s products and services
  • Builds long-term, trusting relationships with referral sources
  • Evaluates interrelationship of referral source, medical team and reimbursement concerns and strives to make fact-based, balanced decisions
  • Promotes products and services provided to all health care professionals that they may encounter daily
  • Educates referral sources on product guidelines, documentation, and the use of products and services provided by AdaptHealth
  • Collaborates with intake, customer service, document collection as well as other functional areas within the company to help process orders and drive sales growth
  • Communicates and explains Medicare and private insurance procedures, pricing information, and product information to referral sources
  • Generates a steady stream of referrals, selling all offered services, to meet sales growth goals for this position and territory
  • Creates, executes, and manages a territory call plan, and utilizes AdaptHealth Referral Management application to document sales calls, schedule, and sales plan
  • Increases referral volume from assigned accounts by promotion within business lines and cross selling among business lines through regular and ongoing solicitation/facilitation of referral orders from assigned accounts
  • Works with the Intake team to obtain complete referral information and medical documentation to ensure complete, accurate and timely processing of referrals
  • Accepts referrals based on a current knowledge and understanding of Medicare, Medicaid, and private insurance reimbursement guidelines for services and/or equipment
  • Suggests alternative equipment as warranted based on reimbursement limitations
  • Acts as a resource to all external customers to facilitate resolution of AH patient issues in coordination with members of the operational teams within AH to assure optimal patient and referral source outcomes
  • Participates in obtaining MD orders/signatures for appropriate documentation and original prescriptions while on-site when the Intake team is unable to do so
  • Promotes ePrescribe platforms for streamlined referral and documentation processes
  • Delivers and picks up required paperwork from physicians such as doctors’ orders and chart notes
  • Conducts sales & service rounds in assigned facilities promoting availability for order processing, set-up, and patient equipment education
  • Assists in obtaining referral source profile information
  • Identifies programs or initiatives that potentially could increase company revenues, decrease costs, and/or increase referral source/patient satisfaction
  • Retain knowledge of and consistently adhere to procedures for the use of Personal Protective Equipment (PPE), infection control and hazardous materials handling
  • Shares information and expertise with peers to enable them to be effective
  • Participates in team meetings as requested
  • Completes Boot Camp Sales Training courses
  • Completes assigned compliance training and other educational programs as required
  • Develops and maintains working knowledge of services, products, insurance guidelines, eligibility, and reimbursement for patients
  • Maintains compliant with AdaptHealth’s Compliance Program
  • Perform other related duties as assigned
  • In limited circumstances and with Regional Operation Leadership approval (VP or EVP) the Clinical Respiratory Partner will be allowed to conduct a setup on their new business
Desired Qualifications
  • Extensive knowledge of Ventilation related disease states, products, and industry
  • Motivation for sales
  • Strong persuasion skills
  • Skilled and fully competent in PAP, Ventilator, Airway Clearance, and Oxygen therapy administration and management
  • Able to perform clinical assessments and make recommendations to physicians
  • Equipment troubleshooting and maintenance skills
  • Excellent relationship building skills and personality
  • Excellent verbal and written communication skills
  • Excellent presentation skills
  • Ability to work independently and with a team
  • Strong analytical and problem-solving skills with attention to detail
  • Ability to prioritize and manage multiple projects
  • Mental alertness and the ability to properly treat confidential information
  • Proficient computer skills and knowledge of Microsoft Office

AdaptHealth provides home medical equipment and related services to support patients living outside of hospitals. It sells and rents devices such as wheelchairs, ventilators, CPAP machines, thermometers, pulse oximeters, and sanitizing equipment, and also offers resupply and ongoing support; equipment is delivered, installed, maintained, and restocked as needed. The company serves patients, healthcare professionals, and insurance companies by coordinating direct sales, rentals, and insurance partnerships to ensure continuous home-based care. Its goal is to empower patients to live life at home with accessible, coordinated equipment and care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Phoenixville, Pennsylvania

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $819.8M with 9.1% organic growth, raised 2026 guidance to $3.5B.
  • $1.1B credit facility in April 2026 extends maturities to 2031, cuts debt costs 25bps.
  • WellSpan Medical Equipment acquisition effective June 1 bolsters Pennsylvania presence.

What critics are saying

  • Lincare erodes 35% sleep share by diverting 15-20% capitated patients within 6-12 months.
  • CMS prior authorization delays reimbursements 60-90 days, inflating $50M receivables in 3-6 months.
  • Q1 2026 GAAP losses breach $1.1B facility covenants if leverage tops 4.5x within 12-24 months.

What makes AdaptHealth unique

  • AdaptHealth leads with AI-powered order processing pilots launched in 2025.
  • Nationwide 680-location network serves 4.2 million patients across 50 states.
  • Largest patient transition history via 10 million-member capitated contract.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Stock Titan
Apr 13th, 2026
AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs.

AdaptHealth (NASDAQ: AHCO) extends debt maturities and lowers interest costs. Filing Impact Filing Sentiment Rhea-AI Filing summary. AdaptHealth Corp. entered into a new senior secured credit facility totaling $1.1 billion, replacing its prior credit arrangements and extending its debt maturity profile. The package includes a $325 million Term Loan A, a $325 million delayed draw term loan, and a $450 million revolving credit facility. Proceeds from the new term loan repaid the existing term loan and prior credit agreement, while the delayed draw facility is intended to redeem the 6.125% Senior Notes due 2028, lowering interest expense. The facility, maturing in April 2031, features lower SOFR-based pricing tied to leverage covenants and is supported by recent credit rating upgrades. The company states the transaction does not change its full-year 2026 guidance. Positive. * The new $1.1 billion senior secured credit facility extends AdaptHealth's debt maturity to April 2031, reduces SOFR-based pricing margins, and is expected to lower weighted average cost of debt by at least 25 bps after redemption of the 6.125% Senior Notes due 2028. Negative. Insights. Refinancing extends debt maturities to 2031 and modestly lowers borrowing costs. AdaptHealth has arranged a $1.1 billion senior secured credit facility, combining a term loan, delayed draw term loan, and revolver. This replaces its prior term loan and smaller revolver, consolidating bank debt under a single agreement with standardized covenants. The company plans to use the $325 million delayed draw term loan to redeem its 6.125% Senior Notes due 2028, once callable at par, which should reduce interest expense. The facility matures in April 2031, roughly two years later than the prior structure, easing near-term refinancing risk. Pricing is now indexed to the Consolidated Total Leverage Ratio, with SOFR margins as low as 1.125%. Management estimates at least a 25 bps reduction in weighted average cost of debt after note redemption. Recent rating upgrades by S&P and Moody's likely supported these terms, and the company indicates its 2026 guidance remains unchanged, framing this as a balance-sheet optimization rather than a shift in operating outlook. 8-K event classification. 5 items: 1.01, 1.02, 2.03, 7.01, 9.01 Key figures. Total new credit facility: $1.1 billion Term Loan A size: $325 million Delayed Draw Term Loan: $325 million +5 more Key terms. Delayed Draw Term Loan, Revolving loan commitments, Consolidated Total Leverage Ratio, Term SOFR, +2 more 04/13/2026 - 08:11 AM Faq. What did AdaptHealth (AHCO) announce regarding its new credit facility? AdaptHealth closed a new $1.1 billion senior secured credit facility. It includes a $325 million Term Loan A, a $325 million Delayed Draw Term Loan, and a $450 million revolving credit facility, replacing its prior term loan and smaller revolver. How will AdaptHealth use the proceeds from the new Term Loan A and Delayed Draw Facility? The $325 million Term Loan A was used to fully repay the company's existing term loan and prior credit agreement. The $325 million Delayed Draw Facility is intended to redeem the 6.125% Senior Notes due 2028 once they become callable at par in August 2026. How does the new AdaptHealth credit facility affect debt maturities? The new senior secured credit facility matures in April 2031, extending AdaptHealth's debt maturity profile by roughly two years. This longer runway reduces near-term refinancing risk and supports the company's ability to pursue its strategic and operational priorities. What interest rate terms apply to AdaptHealth's new credit facility? Borrowings can be based on a base rate or Term SOFR, plus an Applicable Margin. For SOFR loans, the margin ranges from 1.125% to 2.000% per year, determined by the Consolidated Total Leverage Ratio, replacing the company's prior, higher pricing grid. Will AdaptHealth's new financing change its 2026 financial guidance? AdaptHealth states the new $1.1 billion credit facility is not expected to affect its full-year 2026 guidance. Management frames the transaction as a refinancing that improves terms and flexibility, rather than a change in the company's underlying operating outlook. What role did credit rating upgrades play in AdaptHealth's new facility? Recent rating upgrades by S&P Global Ratings and Moody's Ratings recognized improved performance and a stronger balance sheet. AdaptHealth believes these upgrades, plus consistent free cash flow, helped secure a lower pricing grid and favorable terms on the new credit facility. Filing exhibits & attachments. 2 documents Press releases.

MarketScreener
Apr 13th, 2026
AdaptHealth secures $1.1B credit facility with extended maturity to 2031 and 25bps lower debt cost

AdaptHealth Corp., a US provider of home medical equipment and services, has closed a $1.1 billion senior secured credit facility, consisting of a $325 million term loan, a $325 million delayed draw facility and a $450 million revolving credit line. The new facility replaces the company's existing debt arrangements. The refinancing extends AdaptHealth's debt maturity to April 2031, approximately two years beyond the previous facility, whilst reducing borrowing costs. The interest rate pricing grid has been lowered, with the lowest tier falling from 1.50% to 1.125% over SOFR. The company expects its weighted average cost of debt to decrease by at least 25 basis points once its 6.125% senior notes due 2028 are redeemed. The improved terms follow recent credit rating upgrades from S&P Global Ratings and Moody's Ratings.

Investing.com
Mar 31st, 2026
OEP entities purchase $4.4M in AdaptHealth shares at $9.81-$9.95

Entities associated with One Equity Partners have acquired $4.4 million worth of AdaptHealth Corp shares across two transactions. On 19 March 2026, the entities purchased 727 shares at $9.94 per share, followed by 447,100 shares at $9.91 per share on 20 March 2026. The purchases occurred at prices ranging from $9.81 to $9.95. Following these transactions, OEP entities now hold 16,312,698 shares of AdaptHealth. The stock currently trades at $11.29, up nearly 9% over the past week. The transactions come after AdaptHealth reported fourth-quarter 2025 earnings that missed EPS expectations but exceeded revenue forecasts at $846.3 million. RBC Capital maintains an Outperform rating with a $13 price target, whilst Leerink Partners lowered its target to $12.

Yahoo Finance
Feb 24th, 2026
AdaptHealth posts $3.2B revenue with new capitated contract expected to drive 5%-6% growth in 2026

AdaptHealth reported 2025 net revenue of $3.245 billion, down 0.5% on a reported basis but up 1.7% organically, with adjusted EBITDA of $616.7 million representing a 19.0% margin. Full-year free cash flow reached $219.4 million, exceeding guidance. The company launched a new operating model that improved setup times and deployed technology pilots including AI-powered order processing. It went live early on a major capitated contract covering approximately 50,000 members across three Mid-Atlantic states, which management expects could ultimately serve 10 million patients and contribute 5%-6% growth in 2026. For 2026, AdaptHealth guided net revenue of $3.44-3.51 billion, adjusted EBITDA of $680-730 million, and free cash flow of $175-225 million. The company ended 2025 with net debt of $1.694 billion and net leverage of 2.75x.

LebTown
May 14th, 2025
WellSpan Health sells durable medical equipment business to AdaptHealth

WellSpan Health has sold its durable medical equipment business, WellSpan Medical Equipment, to national firm AdaptHealth, effective June 1.

INACTIVE